Home » Topics » Regulatory » NMPA

NMPA
RSS

High-dose EPIAO approved in China to treat chemotherapy-associated anemia

July 14, 2011

No Comments

Chinese health authorities approve Novo Nordisk's Victoza for type 2 diabetes

March 16, 2011

No Comments

Hutchison MediPharma begins phase I trial of fruquintinib in China

Feb. 2, 2011

No Comments

TPIAO approved in China for idiopathic thrombocytopenic purpura

Jan. 26, 2011

No Comments

Sinovac receives SFDA approval to begin trials of EV-71 vaccine

Dec. 29, 2010

No Comments

Aoxing Pharma begins trial of sublingual buprenorphine/naloxone for opioid addiction

Dec. 13, 2010

No Comments

MicuRx files IND for MRX-I antibiotic in China

March 16, 2010

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

NMPA
RSS

High-dose EPIAO approved in China to treat chemotherapy-associated anemia

Chinese health authorities approve Novo Nordisk's Victoza for type 2 diabetes

Hutchison MediPharma begins phase I trial of fruquintinib in China

TPIAO approved in China for idiopathic thrombocytopenic purpura

Sinovac receives SFDA approval to begin trials of EV-71 vaccine

Aoxing Pharma begins trial of sublingual buprenorphine/naloxone for opioid addiction

MicuRx files IND for MRX-I antibiotic in China

Today's news in brief

Today's news in brief

J&J’s Ottava robotic system approved for US pivotal trial

In muscular dystrophies, gene therapies race the clock

‘Evo’ AI can design complete genomes

NMPA RSS

NMPA
RSS